Fibrinolytic activity in malignant disease.


Resting fibrinolytic activity and fibrinolytic capacity were compared in 31 patients with malignant disease and in 24 control subjects without malignant disease. Patients with malignant disease had a lower mean fibrinolytic activity: this was particularly marked in those with disseminated disease. In contrast, patients with malignant disease had a fibrinolytic capacity which did not differ from that of the control subjects.

Cite this paper

@article{Rennie1975FibrinolyticAI, title={Fibrinolytic activity in malignant disease.}, author={J. A. N. Rennie and Derek Ogston}, journal={Journal of clinical pathology}, year={1975}, volume={28 11}, pages={872-4} }